PubRank

A J Scheen

Author PubWeight™ 3.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [The epidemic of metabolic diseases, a major problem of public health]. Rev Med Liege 1999 0.78
2 [Clinical study of the month. Prolonged insulin independence after transplantation of islets of Langerhans in a patient with type 1 diabetes: achievement of a dream?]. Rev Med Liege 2000 0.77
3 [Clinical study of the month. Usefulness of increasing HDL cholesterol in secondary prevention of coronary heart disease: results of the VA-HIT study]. Rev Med Liege 1999 0.76
4 [Clinical study of the month. The CAPPP study: "The Captopril Prevention Project"]. Rev Med Liege 1999 0.76
5 [Hypercholesterolemia-related cardiovascular risk: a continuum from a notion of normality, intervention threshold and therapeutic objectives]. Rev Med Liege 1999 0.76
6 [Drug of the month. Torasemide (Torrem)]. Rev Med Liege 1994 0.75
7 [Drug-clinics. The hue and cry over central appetite suppressants!]. Rev Med Liege 1997 0.75
8 [Therapeutic update 1997-1998]. Rev Med Liege 1998 0.75
9 [Multiple endocrine neoplasms: medical therapy]. Rev Med Liege 1993 0.75
10 [Lamotrigine (Lamictal)]. Rev Med Liege 1997 0.75
11 [Drug clinics. How I treat a patient with a low concentration of HDL cholesterol]. Rev Med Liege 1998 0.75
12 [Clinical case of the month. Prolonged spontaneous remission of a typical type 1 diabetes]. Rev Med Liege 1995 0.75
13 [On the inapplicability of certain therapeutic guidelines in practice: the example of reimbursement for hypolipidemic agents in Belgium]. Rev Med Liege 2000 0.75
14 [Study of the month. Long-term (1-2 years) clinical trials with orlistat, a new drug for the treatment of obesity]. Rev Med Liege 1999 0.75
15 [Clinical study of the month. The LIPID study: "long-term intervention with pravastatin in ischaemic disease"]. Rev Med Liege 1999 0.75
16 [Drug of the month. fosinopril (Fosinil)]. Rev Med Liege 1994 0.75
17 [Pharma-clinics. Drug of the month. Tacrine (Cognex)]. Rev Med Liege 1996 0.75
18 [How I explore... insulin resistance in clinical practice]. Rev Med Liege 1996 0.75
19 [Pharma-clinics. Doping with erythropoietin or the misuse of therapeutic advances]. Rev Med Liege 1998 0.75
20 [Pharma-clinics. Drug of the month. Tramadol (Dolzam)]. Rev Med Liege 1996 0.75
21 [How I investigate the new criteria for the diagnosis of diabetes mellitus]. Rev Med Liege 1997 0.75
22 [Could homeopathy find its legitimacy in the "positive" results of a meta-analysis?]. Rev Med Liege 1997 0.75
23 [Pharmaco-economics of hypolipidemic agents: analysis of factors influencing the cost-effectiveness relation]. Rev Med Liege 1998 0.75
24 [Image of the month. What collapse!]. Rev Med Liege 1998 0.75
25 [Therapeutic update 1997-1998 (1). First part]. Rev Med Liege 1998 0.75
26 [How I treat... an obese patient with type 2 diabetes]. Rev Med Liege 1994 0.75
27 [Drug of the month. Fluvastatin (Lescol)]. Rev Med Liege 1997 0.75
28 [The unstable diabetic patient: from physiopathology to treatment]. Rev Med Liege 1995 0.75
29 [Pharmaclinics. Drug of the month. Captopril (Capoten) in diabetic nephropathies]. Rev Med Liege 1995 0.75
30 [Current therapeutic agents 1995-1996]. Rev Med Liege 1996 0.75
31 [Drug of the month. Lacidipine (Motens)]. Rev Med Liege 1994 0.75
32 [From obesity to diabetes or the natural history of abnormalities in the secretion and action of insulin]. Rev Med Liege 1992 0.75
33 [How I explore.... an adult subject with suspected hypothyroidism]. Rev Med Liege 1996 0.75
34 [Evidence-based medicine. Input of controlled clinical trials]. Rev Med Liege 2000 0.75
35 [Pharma-clinics. How I treat... A patient with orthostatic hypotension]. Rev Med Liege 1997 0.75
36 [Drug of the month. Paroxetine (Seroxar, Aropax)]. Rev Med Liege 1994 0.75
37 [How I diagnose... anorexia nervosa]. Rev Med Liege 1995 0.75
38 [Pharma-clinics. Drug of the month. Fluticasone propionate (Flixotide)]. Rev Med Liege 1996 0.75
39 [Drug of the month. Lansoprazole (DakaR)]. Rev Med Liege 1995 0.75
40 [Hypoglycemic sulfamides, 50 years after Loubatiere]. Rev Med Liege 1996 0.75
41 [Lessons from the "United Kingdom Prospective Diabetes Study"]. Rev Med Liege 1998 0.75
42 [Pharma-clinics. Medication of the month. Glimepiride (Amarylle)]. Rev Med Liege 2000 0.75
43 [Clinical study of the month. After DCCT, the EDIC study]. Rev Med Liege 2000 0.75
44 [Estrogen therapy after menopause and cardiovascular protection: discordance between epidemiologic observations and the results of therapeutic trials] . Rev Med Liege 2000 0.75
45 [How I explore... a patient with orthostatic hypotension]. Rev Med Liege 1997 0.75
46 [Pharma-clinics. Medication of the month. Moxonidine (Moxon)]. Rev Med Liege 2000 0.75
47 [Drug of the month. Moclobemide (Aurorix)]. Rev Med Liege 1994 0.75
48 [Drug-clinics. The drug of the month. Imitrex nasal spray (sumatriptan)]. Rev Med Liege 1997 0.75
49 [Antioxidant vitamins in the prevention of cardiovascular diseases. First part: epidemiologic studies]. Rev Med Liege 2000 0.75